ABSTRACT JMJD3 H3K27me3 demethylase plays an important role in the transcriptional response to different signaling pathways; however, the mechanism by which it facilitates transcription has been unclear. Here we show that JMJD3 regulates transcription of transforming growth factor β (TGFβ)-responsive genes by promoting RNA polymerase II (RNAPII) progression along the gene bodies. Using chromatin immunoprecipitation followed by sequencing experiments, we show that, upon TGFβ treatment, JMJD3 and elongating RNAPII colocalize extensively along the intragenic regions of TGFβ target genes. According to these data, genome-wide analysis shows that JMJD3-dependent TGFβ target genes are enriched in H3K27me3 before TGFβ signaling pathway activation. Further molecular analyses demonstrate that JMJD3 demethylates H3K27me3 along the gene bodies, paving the way for the RNAPII progression. Overall these findings uncover the mechanism by which JMJD3 facilitates transcriptional activation.
INTRODUCTION
Cellular identity and function are determined by a combination of signaling pathways that converge on chromatin to regulate the transcription of specific sets of genes. Thus chromatin is the final platform where cellular signals are integrated in order to control gene transcriptional programs. Chromatin accessibility is regulated by epigenetic mechanisms, particularly by covalent histone modi fications. Among these, methylation of Lys27 of histone H3 (H3K27me3) has been found to be a key regulator of cell homeo stasis and embryonic development (Morey and Helin, 2010; Margueron and Reinberg, 2011) . Enhancer of Zeste Homologues 1 and 2 (EZH1/2) are the enzymes responsible for the H3K27 methy lation reaction (Cao et al., 2002; Czermin et al., 2002; Kuzmichev et al., 2002) . They are part of Polycomb repressive complex 2 (PRC2), which, together with the PRC1 complex, establishes the repressive state associated with H3K27me3 marks (Cao et al., 2002; Lois et al., 2010) . Although H3K27me3 has been described as a stable histone mark, recent findings show that two new his tone demethylase (HDM) enzymes, JMJD3 and UTX, can cause this modification to revert (Agger et al., 2007; De Santa et al., 2007; Lan et al., 2007; Lee et al., 2007) . Both JMJD3 and UTX contain a Jumonji C (JmjC) domain responsible to the HDM catalytic activity (Agger et al., 2007; De Santa et al., 2007; Lan et al., 2007; Lee et al., 2007) . These two genes play an essential role during devel opment, as many key developmental promoters are often marked by H3K27me3 (Boyer et al., 2006; Bracken et al., 2006; Lee et al., 2006; Pan et al., 2007) . In particular, they derepress HOX genes and a subset of neural and epidermal differentiation genes (Agger et al., 2007; Jepsen et al., 2007; Lan et al., 2007; Lee et al., 2007; Burgold et al., 2008; Sen et al., 2008) . Moreover, it has recently been shown that JMJD3 cooperates with transforming growth fac tor β (TGFβ) and bone morphogenic protein signaling pathways to JMJD3 associates with H3K27me3 gene bodies in TGFβ-stimulated NSCs
The results described in the preceding section suggest that H3K27 methylation/demethylation at the transcribing regions might play a pivotal role in TGFβ response. To test this hypothesis, we investi gated the binding sites of JMJD3 in NSCs treated with TGFβ by ChIPseq ( Figure 2A ). We first checked the efficiency of the JMJD3 antibody used in our experimental conditions (Supplemental Figure  S2A ). After sequencing of JMJD3associated DNA fragments, we identified 61,610 peaks. In agreement with previous data (Estarás et al., 2012) and consistent with what was identified in other cell contexts (De Santa et al., 2009) , JMJD3 peaks were distributed across the intergenic and intragenic regions ( Figure 2B and Supple mental Figure S2B ).
Next we compared the distribution of JMJD3 around TSS, TES, and gene bodies between JDTA genes and the remaining genes in the array. Results in Figure 2C show that the former exhibited higher levels of bound JMJD3 both in TSS and gene bodies. Remarkably, JMJD3 was distributed along the intragenic regions until the TES ( Figure 2C ).
We then examined whether JMJD3 binds H3K27me3 gene bod ies upon TGFβ treatment. We observed that JMJD3 associates with the 90.9% of methylated genes ( Figure 2D , orange box), suggesting that JMJD3 is recruited to these regions upon signal activation.
To further explore this idea, we tested whether TGFβ signal was required to recruit JMJD3 to gene bodies by ChIP followed by qPCR experiments. Results in Figure 2 , E and F, show that, 3 h after TGFβ treatment, JMJD3 was recruited to the intragenic regions of the TGFβresponsive gene neurogenin 2 (Neurog2; Estarás et al., 2012) . This recruitment was not observed for the gene G6pd2 (Figure 2 , E and F), a non-TGFβregulated gene used as a negative control. Of interest, Smad3 was not targeted to the intragenic region upon TGFβ treatment, suggesting that JMJD3 binding to the gene bod ies is not led by Smad3 (Supplemental Figure S3A) , in contrast to what was found for promoters (Estarás et al., 2012) . In addition, TGFβ signaling did not affect JMJD3 subcellular distribution (Sup plemental Figure S3B ). These findings reinforce the idea that the binding of JMJD3 to the intragenic regions facilitates transcription.
Because our data indicate that JDTA genes are enriched in H3K27me3 before TGFβ activation ( Figure 2D ), we tested whether the binding of JMJD3 to intragenic regions leads to H3K27me3 demethylation. To this end, we analyzed changes in H3K27me3 lev els along the Neurog2 gene body upon TGFβ activation. Results in Figure 2G indicate that H3K27me3 levels decreased 3 h after cy tokine addition in the analyzed regions. To further characterize the contribution of JMJD3 to the observed demethylation, we analyzed the H3K27me3 levels in JMJD3 KD cells. As shown in Supplemental Figure S3C , no significant changes were detected in H3K27me3 lev els in TGFβstimulated JMJD3 KD cells. These data demonstrate that the H3K27me3 demethylation observed in the intragenic re gions of JDTA genes in control cells is dependent on JMJD3. This is supported by ChIPseq data analysis, showing an overall lack of co incidence between nucleotides bound by H3K27me3 and JMJD3 (Supplemental Figure S3D) . In summary, these results support the notion that JMJD3 association with gene bodies promotes H3K27me3 demethylation.
JMJD3 interacts with RNAPII-S2p
The results described here reveal an enrichment in JMJD3 along the gene body for JDTA genes. This suggests that JMJD3 might be in volved in RNAPII elongation. To explore this hypothesis, we investi gated the association of JMJD3 with elongating RNAPII. Using control neuronal differentiation and cell fate specification in early neural development Estarás et al., 2012) . These findings point to an important role of JMJD3 and UTX, and hence H3K27me3 demethylation, in transcriptional regulation of specific signaling pathways. However, the mechanism by which these en zymes facilitate transcription remains unclear. Of interest, genome wide analyses recently showed that JMJD3 binds to promoters, but also to gene bodies, in neural stem cells (NSCs; Estarás et al., 2012) and macrophages (De Santa et al., 2009 ). In addition, it has been reported that UTX localizes at the intragenic regions of mus clespecific genes during myogenesis (Seenundun et al., 2010) . Moreover, recent data indicate that the H3K27me3 pattern moves from promoters to intragenic regions after cell differentiation (Hawkins et al., 2010) . When considered together, these data led us to hypothesize that H3K27me3 HDMs might play an important role at intragenic regions in transcriptional response to signaling pathway activation.
To address this hypothesis, we analyzed the contribution of genebody-associated JMJD3 to TGFβ transcriptional response. Our data demonstrate that JMJD3 is required to promote transcrip tion elongation by demethylating H3K27me3 at the transcribed re gions of TGFβresponsive genes.
RESULTS

Genome-wide H3K27me3 distribution in NSCs
Genomewide analysis has shown that JMJD3 localizes on gene bodies in TGFβstimulated NSCs (Estarás et al., 2012) . However, we still do not know how the association of JMJD3 to intragenic regions contributes to TGFβmediated transcriptional response. To address this problem, we first analyzed the global H3K27me3 profile in NSCs by applying the chromatin immunoprecipitation followed by se quencing (ChIPseq) technique ( Figure 1A ). First, we validated the H3K27me3 antibody by ChIP, followed by quantitative PCR (qPCR) of two wellknown H3K27me3 targets and a negative control (Sup plemental Figure S1A ). Using the same conditions, we performed H3K27me3 ChIP assays; then libraries were generated and se quenced with an Illumina Genome Analyzer II. The total number of peaks detected after input normalization was 16,168.
We then examined the genomic distribution of the H3K27me3 peaks. Our results, in accordance with findings from other cell contexts (Hawkins et al., 2010; Kim et al., 2011) , showed that the H3K27me3 mark is abundant within the intragenic regions ( Figure  1B ). More precisely, we identified 5009 H3K27me3 peaks along the gene bodies and 982 around the transcription start site (TSS; defined as ±1000 base pairs; Figure 1C ). These results are in good agreement with previous data on specified cells (Hawkins et al., 2010) , showing that H3K27me3binding sites are spread along the intragenic regions and decrease around the transcription end site (TES; Figure 1 , D and E). A different distribution was described for embryonic stem cells (Barski et al., 2007; Mikkelsen et al., 2007) , in which H3K27me3 is mainly localized around the TSS and promoters.
We previously showed that JMJD3 is essential to activate a set of TGFβinduced genes in NSCs (Estarás et al., 2012, and Figure 1F ). To characterize the dynamics of H3K27 methylation, we analyzed the H3K27me3 levels in the set of TGFβresponsive genes that require JMJD3 to be activated (fold change [FC] ≥ 1.5, p ≤ 0.05; 61 genes), from now on abbreviated as JDTA genes ( Figure 1F and Supplemental Table S1 ). Results in Figure 1G and Supplemental Figure S1B show that JDTA genes ( Figure 1G , orange box) are en riched in H3K27me3 compared with the remaining genes in the ar ray (20,636; Figure 1G , green box, and Supplemental Figure S1B ). Figure 3D ). Because we were interested in JMJD3 association with RNAPII S2p in JDTA genes, we investigated the occupancy of both fac tors on their gene bodies. We analyzed the number of genes that associate both JMJD3 and RNAPIIS2p factors. We observed JMJD3 bound to most of RNAPIIS2p-positive genes ( Figure 3E ). It is striking that highresolution analysis showed that, on gene bodies, 46.72% of the nucleotides occupied by RNAPIIS2p were shared with JMJD3 ( Figure 3G , orange box) in JDTA genes. This figure dropped to 18.89% for the remaining genes in the array ( Figure 3G, green box) . Similarly, 68.8% of RNAPIIS2p peaks (52 of 77) colocalize with JMJD3 peaks in the coding region of the JDTA genes (Supplemental Figure S4B) . Figure 3F shows the co localization of RNAPIIS2p and JMJD3 for five genes from the set of JDTA genes.
Taken together, these results indicate that, in TGFβstimulated NSCs, JMJD3 and RNAPIIS2p are broadly associated and distrib uted along the gene bodies of JDTA genes. coimmunoprecipitation (CoIP) experiments, we found that overex pressed JMJD3 interacts with the elongating form of RNAPII (phos phorylated at Ser2; RNAPIIS2p) but not with unphosphorylated RNAPII ( Figure 3A) . We confirmed this result by CoIP experiments with endogenous proteins, which showed that JMJD3 and RNAPII S2p interact in NSCs ( Figure 3B ), pointing to the possibility that JMJD3 forms part of the elongating complex.
JMJD3 and RNAPII colocalize along the gene bodies of TGFβ target genes
The ability of the JMJD3 and RNAPIIS2p to coimmunoprecipitate suggests that both factors could bind a subset of common target genes. To investigate this possibility, we identified the genomic binding sites of RNAPIIS2p in TGFβtreated NSCs by sequencing DNA fragments of immunoprecipitated chromatin ( Figure 3C ). To perform the ChIPseq experiment, we used a ChIPgrade antibody that efficiently immunoprecipitates the RNAPIIS2p form (Supple mental Figure S4A ). We obtained 24,997 peaks for RNAPIIS2p after input normalization. Most of the peaks were associated with the moters. To do that, we performed Cdk9 ChIPqPCR experiments in C KD and JMJD3 KD cell lines in the absence and presence of TGFβ. The results (Supplemental Figure S5A) showed that Cdk9 is recruited to the Neurog2 promoter in TGFβstimulated control cells. Never theless, the low levels of JMJD3 significantly affected Cdk9 binding to the Neurog2 gene. These findings are in accordance with the lack of RNAPIIS2P observed in JMJD3 KD cells ( Figure 4D ). It is worth mentioning that the observed effect of JMJD3 on transcription is not because JMJD3 influences Smad3 binding to promoters (Estarás et al., 2012) or affects Smad3 translocation into the nucleus upon TGFβ treatment (Supplemental Figure S5B ). Overall these observations suggested that JMJD3 is required to allow RNAPII progression through the Neurog2 gene body ( Figure 4D ).
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JMJD3 binding to gene bodies depends on active transcription
The experiments described here showed that JMJD3 is distrib uted along the gene bodies of TGFβactivated genes in associa tion with RNAPIIS2p. We then sought to investigate whether the presence of JMJD3 in the intragenic regions require active tran scription. To this end, we treated NSCs with DRB, a pharmacologi cal inhibitor of transcriptional elongation. We first confirmed that under our experimental conditions (DRB, 75 μM, 4 h, added 1 h before TGFβ cytokine treatment), 1) DRB treatment blocked RNAPII Ser2 phosphorylation ( Figure 5A ), and 2) TGFβ induced expression of the gene under study ( Figure 5B ). In addition, to rule out any nonspecific effect of the drug on TGFβ response, we con firmed that it did not affect Smad3 translocation into the nucleus after TGFβ stimulation ( Figure 5C ). We then examined JMJD3
JMJD3 is essential for RNAPII elongation
To assess whether colocalization of JMJD3 with RNAPIIS2p plays any role in stimulating transcription, we analyzed the recruitment of RNAPII in the presence or absence of JMJD3, using C KD and JMJD3 KD NSCs. Then we performed ChIP assays on a JDTA gene (Neurog2) and a negative control gene (G6pd2) for both C KD and JMJD3 KD NSCs ( Figure 4A and Estarás et al., 2012) to investigate the RNAPII recruitment on Neurog2 promoter upon TGFβ treat ment, using an antibody that recognizes the Nterminus of RNAPII (N20). Results in Figure 4B indicate that RNAPII was targeted to the Neurog2 promoter in the C KD cell line 0.5 h after TGFβ activation. Of interest, we observed similar behavior for RNAPII promoter as sociation in the JMJD3 KD cell line ( Figure 4B ). These findings dem onstrate that JMJD3 is not essential for RNAPII initial targeting to promoters.
Then we tested whether JMJD3 affects the levels of elongating RNAPII at transcribing regions upon TGFβ treatment. ChIP assays showed a clear enrichment in RNAPIIS2p on the Neurog2 gene af ter TGFβ treatment in C KD cells, correlating with mRNA accumula tion ( Figure 4A ). Of interest, this RNAPIIS2p recruitment was absent in JMJD3 KD cells ( Figure 4C ), in agreement with the lack of active transcription ( Figure 4A ). To further understand the influence of JMJD3 on RNAPIIS2p, we analyzed the recruitment of the PTEFb elongation factor. The catalytic subunit of PTEFb complex is Cdk9, which phosphorylates Ser2 of the CTD domain of RNAPII. Apart from its extensive role as an essential factor for transcription elonga tion (Peterlin and Price, 2006) , it was also found that Cdk9 phospho rylates Smad3, promoting its activity (Alarcon et al., 2009) . On that basis, we tested whether JMJD3 regulates Cdk9 binding to the pro regulates the transcription of TGFβresponsive genes by allowing RNAPII progression through the gene bodies. We demonstrate that the contribution of JMJD3 to transcription not only occurs at the promoter level (Estarás et al., 2012) , but also requires migration of JMJD3 to the H3K27me3 intragenic regions to regulate the process of transcriptional elongation ( Figure 5E ). The correlation between JMJD3 presence on gene bodies and H3K27me3 demethylation suggests that active demethylation at transcribing regions is impor tant for RNAPII progression.
Our data show the existence of broad domains of H3K27me3 enrichment along the gene bodies. Similar data were previously re ported (Hawkins et al., 2010; Young et al., 2011) , showing that H3K27me3 domains are expanded on committed cells. Our study not only confirms the H3K27me3 expansion along the transcribing regions, but it also sheds light on the mechanism by which intragenic H3K27me3 demethylation is coupled to transcriptional elongation. recruitment within the transcribing regions upon TGFβ treatment. Analysis of JMJD3 ChIP in Figure 5D shows that TGFβinduced JMJD3 enrichment within the gene body was impaired in the presence of DRB. Of interest, DRB treatment blocked specifically JMJD3 association to the intragenic regions, since JMJD3 binding to promoter was not affected ( Figure 5D, region 1 ). These data demonstrate that the presence of JMJD3 in the gene bodies is linked to active transcription.
Overall these findings strongly support that JMJD3 HDM has a key role in gene bodies in allowing transcription elongation to proceed.
DISCUSSION
Our results provide new insights into the transcriptional regulatory mechanism mediated by JMJD3. In this study we show, using ge nomewide experiments and further molecular analysis, that JMJD3 The JMJD3 contribution to transcription regulation occurs through a two-step process. In the first step, JMJD3 is recruited to TGFβ-target genes by transcription factor Smad3 (Estarás et al., 2012) . In the second step, JMJD3 migrates into the H3K27me3-enriched gene bodies to regulate the process of transcriptional elongation.
histone H3 (ab1791; Abcam), and rabbit Smad3 (ab28379; Abcam). Antirabbit JMJD3 was kindly provided by K. Helin (Agger et al., 2009) .
Cytoplasmic and nuclear fractionation
Cell fractionation was carried out starting from 3 × 10 6 NSCs un treated or treated with TGFβ (5 ηg/ml) for 3 h. Cell pellets were resuspended in buffer A (10 mM Tris, 10 mM KCl, 1.5 mM MgCl 2 , and protease inhibitors) and kept on ice for 10 min. After centrifu gation at 1500 × g for 5 min, pellets were resuspended in buffer B (buffer A and 1% NP40) and incubated on ice for 5 min before cen trifugation at 5000 × g for 5 min. Supernatant contained the cytoso lic fraction. Pellet was resuspended in buffer C (20 mM Tris, 420 mM NaCl, 1.5 mM MgCl 2 , 25% glycerol, 0.2 mM EDTA, and protease inhibitors) by vortexing and incubating on ice. Lysates were then centrifuged at the highest speed for 20 min at 4°C, and supernatant was collected (nuclear fraction). Extracts were then used for Immunoblotting.
Coimmunoprecipitation and ChIP assays
Coimmunoprecipitation experiments were performed as previously described (Estarás et al., 2012) .
Chromatin immunoprecipitation assays were essentially per formed as described (Frank et al., 2001; Valls et al., 2007) with modi fications: 3 × 10 6 NSCs untreated or treated with TGFβ (5 ng/ml, for the indicated times) were fixed with 0.2 mM di(Nsuccinimidyl) glu tarate (SigmaAldrich), 45 min at room temperature, followed by formaldehyde 1%, 20 min. Fixation was stopped by addition of 0.125 mM glycine. The sonication step was performed in a Bioruptor sonicator (12 min, 30 s on, 30 s off), and 1 mg of protein was used for each immunoprecipitation. Antibody-protein complex was captured with preblocked protein A (AmershamPharmacia Biotech, GE Healthcare BioSciences, Piscataway, NJ), and DNA purification was carried out using Nucleospin Extract II (MachereyNagel, Bethlehem, PA) columns. ChIP DNA was analyzed by qPCR with SYBR Green (Roche, Indianapolis, IN) in a LightCycler 480 PCR system (Roche) using the primers specified in Supplemental Table S2 .
ChIP-seq procedure
Chromatin immunoprecipitation and preparation of samples for se quencing were done essentially as previously described (Estarás et al., 2012) . Before sequencing, ChIP DNA was prepared by simul taneously blunting, repairing, and phosphorylating ends according to manufacturer's instructions (Illumina, San Diego, CA). The DNA was adenylated at the 3′ end and recovered by QIAquick PCR puri fication kit (Qiagen, Valencia, CA) according to the manufacturer's recommendations. Adaptors were added by ligation, and the li gated fragments were amplified by PCR, resolved in a gel, and puri fied by Qiagen columns. Samples were loaded into individual lanes of the flow cell. We generated >26 million 36-base pair reads for each ChIP sample. Reads were mapped with bowtie (Langmead et al., 2009) to the University of California, Santa Cruz (Fujita et al., 2011) , Mus musculus genome, release 9; only sequence reads mapping at unique locations were kept. Peaks were called with SICER (Zang et al., 2009 ) on each sample with Input as control. PeakAnalyzer (SalmonDivon et al., 2010) and CEAS (Ji et al., 2006) were used for peak annotation and profiling. R language and Bioconductor (Gentleman et al., 2004) , including packages Short Read and IRanges (Morgan et al., 2009) , were used for further annotation and statistical analysis.
To derive the metagene profile, we first computed the profile for each gene before computing the average. Specifically, we divided Our results show that with TGFβ, JMJD3 and RNAPIIS2p spread along the H3K27me3 intragenic regions to transcribe the genes and that in the absence of JMJD3, RNAPIIS2p is not able to progress through the H3K27me3enriched genes. This suggests that H3K27me3 demethylation at the intragenic regions might provide an additional requirement to trigger transcriptional activation. It is also possible that other factors different from histones might be JMJD3 targets, such as Smads, RNAPII, or other components of the transcription machinery. However, the fact that JMJD3 is required to activate only a subset of genes in response to TGFβ suggests that the major JMJD3 target is not a general transcription factor. Another possibility is that JMJD3 (in addition to its HDM function) plays a demethylatingindependent role for these genes, as proposed for other genes (Miller et al., 2010) .
There are several examples of factors that spread along the tran scribing region of genes with RNAPII, such as the RNA processing machinery (Pandit et al., 2008) . This is also the case for UTX, which is associated with the intragenic region of genes transcribed by RNAPII (Seenundun et al., 2010) and colocalizes with the elongating form of RNAPII (Smith et al., 2008) . Moreover, it was recently shown that JMJD3 and UTX activate Tbox family-dependent gene tran scription by interacting with Brg1 (Miller et al., 2010) . Of interest, Brg1 facilitates transcription elongation (SubtilRodriguez and Reyes, 2010) . Thus JMJD3 may promote RNAPII progression through the gene bodies by altering their chromatin architecture, by H3K27me3 demethylation of the transcribing regions, and pos sibly through the interaction with Brg1 or other chromatinmodify ing factors. It was also recently shown that JMJD3, together with KIAA1718 histone demethylase, promotes transcription elongation by contributing to the recruitment of SPT6 and SPT16 elongation factors to gene promoters in response to TPA (Chen et al., 2012) . Accordingly, we show that JMJD3 contributes to the recruitment of the Ser2PCTD kinase Cdk9 on the neurogenin 2 promoter. Taken together, these results point to multiple roles of JMJD3 in transcrip tion elongation probably through HDM activity-dependent and -independent mechanisms.
Whether the proposed JMJD3 role is specific for the TGFβ sig naling pathway needs further investigation. However, given the wide spectrum of signaling pathways that act through JMJD3 activ ity (Jepsen et al., 2007; De Santa et al., 2009; Akizu et al., 2010; Estarás et al., 2012) , we postulate that it may be a general mecha nism to activate genes silenced by H3K27me3. Nonetheless, due to the regulatory function of TGFβ in developmental processes and in cancer, our discovery provides an additional layer for the modula tion of TGFβ signaling pathway outcome, targeting JMJD3 activity on a specific set of TGFβresponsive genes.
MATERIALS AND METHODS
Cell culture
Human 293t cells were grown under standard conditions (BlancoGarcia et al., 2009) . Mouse NSCs were grown as previ ously described (Estarás et al., 2012) .
Antibodies and reagents
TGFβ was acquired from Millipore (Billerica, MA; GF111), and DRB was purchased from SigmaAldrich (St. Louis, MO). Antibodies used were anti-rabbit trimethyl H3K27 (07449; Millipore), rabbit total RNAPII (N20; sc899x; Santa Cruz Biotechnology, Santa Cruz, CA), rabbit RNAPIIS2p ChIP grade (ab5095; Abcam, Cambridge, MA), mouse RNAPII 8WG16 (ab817; Abcam), rabbit Cdk9 (H169; sc8338; Santa Cruz Biotechnology), goat actin (I19; sc1616; Santa Cruz Biotechnology), mouse βtubulin (MAB3408; Millipore), rabbit each gene into the same number of bins and computed the ge nomic sequencing read densities for each bin. Genes are scaled as follows: 1) ±1 kb from the TSS and ±1 kb from the TES were un scaled, and 2) the region within the gene body extending from TSS to TES was scaled to 3 kb. mRNA extraction and qPCR mRNA was purified with Qiagen columns following the manufac turer's instructions. Reverse transcription was performed with Tran scriptor kit (Roche) following the manufacturer's procedure. qPCR was done with SYBR Green in an LC480 LightCycler using the prim ers specified in Supplemental Table S2 .
Indirect immunofluorescence
Indirect immunofluorescence was essentially performed as de scribed previously .
Statistical analysis
Quantitative data are expressed as mean and SD of at least three biologically independent experiments. The significance of differ ences between groups was assessed using the Student's t test (*p < 0.05; **p < 0.01).
Accession numbers
The genomewide mapping data of H3K27me3, JMJD3, and RNAPII in NSCs reported in the article are available at the Gene Expression Omnibus server (www.ncbi.nlm.nih.gov/geo/) with the accession number GSE38269.
